Uni-Bio Science Group Limited (0690.HK)
HKD 0.07
(0.0%)
HKD 0.07
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -76.36 Million HKD | -1.09% |
| 2022 | -75.54 Million HKD | 3.16% |
| 2021 | -78.01 Million HKD | -256.64% |
| 2020 | -21.87 Million HKD | 66.39% |
| 2019 | -65.08 Million HKD | -254.88% |
| 2018 | -18.33 Million HKD | 19.44% |
| 2017 | -22.76 Million HKD | 37.38% |
| 2016 | -36.35 Million HKD | 63.77% |
| 2015 | -100.35 Million HKD | 16.81% |
| 2014 | -120.62 Million HKD | -114.54% |
| 2013 | -56.22 Million HKD | -148.61% |
| 2012 | 115.67 Million HKD | 77.98% |
| 2011 | 64.99 Million HKD | 641.47% |
| 2010 | 8.76 Million HKD | 128.4% |
| 2009 | -30.86 Million HKD | -25.13% |
| 2008 | -24.66 Million HKD | 13.0% |
| 2007 | -28.35 Million HKD | -141.75% |
| 2006 | 67.91 Million HKD | 16.86% |
| 2005 | 58.11 Million HKD | 26.58% |
| 2004 | 45.91 Million HKD | 8.7% |
| 2003 | 42.23 Million HKD | -46.06% |
| 2002 | 78.3 Million HKD | 437.19% |
| 2001 | 14.57 Million HKD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -71.16 Million HKD | 12.93% |
| 2024 Q1 | -71.16 Million HKD | 6.81% |
| 2023 Q1 | -78.69 Million HKD | -4.18% |
| 2023 Q3 | -76.84 Million HKD | -1.58% |
| 2023 Q2 | -75.64 Million HKD | 3.88% |
| 2023 Q4 | -76.36 Million HKD | 0.62% |
| 2023 FY | -76.36 Million HKD | -1.09% |
| 2022 Q1 | -76.69 Million HKD | 1.69% |
| 2022 Q3 | -79.42 Million HKD | -7.55% |
| 2022 FY | -75.54 Million HKD | 3.16% |
| 2022 Q4 | -75.54 Million HKD | 4.88% |
| 2022 Q2 | -73.84 Million HKD | 3.71% |
| 2021 Q4 | -78.01 Million HKD | 5.58% |
| 2021 FY | -78.01 Million HKD | -256.64% |
| 2021 Q1 | -93.94 Million HKD | -329.49% |
| 2021 Q2 | -89.56 Million HKD | 4.66% |
| 2021 Q3 | -82.62 Million HKD | 7.75% |
| 2020 Q1 | -45.15 Million HKD | 30.61% |
| 2020 FY | -21.87 Million HKD | 66.39% |
| 2020 Q2 | -44.97 Million HKD | 0.41% |
| 2020 Q3 | -22.9 Million HKD | 49.07% |
| 2020 Q4 | -21.87 Million HKD | 4.5% |
| 2019 FY | -65.08 Million HKD | -254.88% |
| 2019 Q1 | -45.97 Million HKD | -150.72% |
| 2019 Q2 | -44.31 Million HKD | 3.62% |
| 2019 Q3 | -66.19 Million HKD | -49.38% |
| 2019 Q4 | -65.08 Million HKD | 1.69% |
| 2018 Q2 | -37.47 Million HKD | 0.0% |
| 2018 FY | -18.33 Million HKD | 19.44% |
| 2018 Q3 | -25.33 Million HKD | 32.38% |
| 2018 Q4 | -18.33 Million HKD | 27.63% |
| 2018 Q1 | -37.47 Million HKD | -64.59% |
| 2017 Q4 | -22.76 Million HKD | 0.0% |
| 2017 FY | -22.76 Million HKD | 37.38% |
| 2017 Q3 | -22.76 Million HKD | 31.69% |
| 2017 Q2 | -33.32 Million HKD | 0.0% |
| 2017 Q1 | -33.32 Million HKD | 8.33% |
| 2016 FY | -36.35 Million HKD | 63.77% |
| 2016 Q4 | -36.35 Million HKD | 0.0% |
| 2016 Q3 | -36.35 Million HKD | 54.27% |
| 2016 Q2 | -79.49 Million HKD | 0.0% |
| 2016 Q1 | -79.49 Million HKD | 20.78% |
| 2015 Q4 | -100.35 Million HKD | 0.0% |
| 2015 FY | -100.35 Million HKD | 16.81% |
| 2015 Q3 | -100.35 Million HKD | 24.81% |
| 2015 Q2 | -133.45 Million HKD | -0.0% |
| 2015 Q1 | -133.45 Million HKD | 0.0% |
| 2014 Q3 | -58.61 Million HKD | 0.0% |
| 2014 FY | -120.62 Million HKD | -114.54% |
| 2014 Q1 | -38.72 Million HKD | 0.0% |
| 2013 Q4 | -38.72 Million HKD | 78.62% |
| 2013 FY | -56.22 Million HKD | -148.61% |
| 2013 Q1 | 115.67 Million HKD | 0.0% |
| 2013 Q2 | -181.13 Million HKD | -256.59% |
| 2013 Q3 | -181.13 Million HKD | 0.0% |
| 2012 Q1 | 64.99 Million HKD | 391.82% |
| 2012 FY | 115.67 Million HKD | 77.98% |
| 2012 Q2 | 75.75 Million HKD | 16.55% |
| 2012 Q3 | 75.75 Million HKD | 0.0% |
| 2012 Q4 | 115.67 Million HKD | 52.7% |
| 2011 Q1 | 8.76 Million HKD | 0.0% |
| 2011 Q4 | -22.27 Million HKD | -153.26% |
| 2011 FY | 64.99 Million HKD | 641.47% |
| 2011 Q3 | 41.82 Million HKD | 0.0% |
| 2010 Q1 | -30.86 Million HKD | 0.0% |
| 2010 Q3 | 3.47 Million HKD | 0.0% |
| 2010 FY | 8.76 Million HKD | 128.4% |
| 2009 FY | -30.86 Million HKD | -25.13% |
| 2008 FY | -24.66 Million HKD | 13.0% |
| 2007 FY | -28.35 Million HKD | -141.75% |
| 2006 FY | 67.91 Million HKD | 16.86% |
| 2005 FY | 58.11 Million HKD | 26.58% |
| 2004 FY | 45.91 Million HKD | 8.7% |
| 2003 FY | 42.23 Million HKD | -46.06% |
| 2002 FY | 78.3 Million HKD | 437.19% |
| 2001 FY | 14.57 Million HKD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| CK Life Sciences Int'l., (Holdings) Inc. | 5.26 Billion HKD | 101.45% |